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Abstract
Purpose Many cancer patients do not have advance directives
(ADs), which may lead to unwanted excessive or aggressive
care when patients have lost decision-making capacity. The
aim of this study was to investigate knowledge and attitudes of
approving ADs and explore factors associated with willing to
designate ADs among cancer patients in China.
Methods We conducted semi-structured interview method in-
vestigating 753 in-patients with cancer in two cancer centers.
Results Of those subjects, none of the cancer patients had an
AD. Only 22.4 % (118 of 526) approved ADs. Comparing with
the disapproved ADs group, the approved ADs groupweremore
likely to discuss the AD with oncologist or nurse (χ2 = 180.4,
p < 0.001) in the cancer center (χ2 = 244.1, p < 0.001), and they
chose more comfort care (χ2 = 18.8, p < 0.001). Most of cancer
patients in the two groups wanted to die at home (72.8 %,
73.7 %, respectively). The older patients (OR, 1.04, 95 % CI,
1.02–1.07, p = 0.001), female (OR, 0.55, 95 % CI, 0.35–0.88,
p = 0.013), with higher education levels (OR, 3.38, 95 % CI,
1.92–5.96, p < 0.001), with religious beliefs (OR, 2.91, 95 %CI,
1.71–4.94, p < 0.001), and with higher scores of ECOG (OR,
1.46, 95 % CI, 1.17–1.82, p = 0.001) were associated with de-
siring for ADs.
Conclusions Our findings indicate that there was a dearth of
knowledge and different attitudes toward approving ADs
among cancer patients, and some factors of demographic
and clinical characteristics influenced their willing to desig-
nate ADs. This research highlights the importance of propa-
gandizing the ADs to the public, especially to the patients, and
further discussing with them when the time is ripe.
Keywords Knowledge . Attitude . Factor . Advance
directive . Cancer patient
Introduction
Over the past 3 decades, there has been more attention paid to
raising patients’ rights of making medical decisions regarding
their own treatment [1–4]. ADs is a process of discussion and a
formalized document with patients and their caregivers about
their wishes for treatment and care planning when they become
unable to make medical decision because of illness or incapacity.
In several countries, ADs has been legalized since the California
Natural Death Act was introduced in 1976 [4–8]. The Patient
Self-Determination Act (PSDA) requires that Medicare and
Medicaid providers inform all patients of their rights to complete
ADs, to make their health care preferences [5]. In China, we do
not strictly distinguish BAdvance Directives,^ BLiving Wills,^
and BAdvance Care Planning^ in practice [9]. The biggest barrier
to the development of ADs is that some people consider
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withholding life-sustaining treatments by ADs for a terminally ill
patient to be an act of passive euthanasia, and the Chinese gov-
ernment is firm in its stand against euthanasia (The criminal law
of the People’s Republic of China, 2015). However, in practice,
the family members often withdraw life-sustaining treatments for
a terminally ill patient [10].
End-of-life (EOL) issues such as advance care planning, pal-
liative care, place of death, and the family roles are valuable to
the cancer patients [11–14]. Studies have found written ADs
were associated with reduced aggressive medical treatment
[15–18], decreased rate of hospitalization [18], and lower hos-
pital charges [17, 19]. Completing ADs keeps caregivers out of
the difficult situation of having to guess what kind of care or
treatment the care recipients accept or refuse. This is also the
reason that the families and caregivers think that ADs are valu-
able. So, it is necessary for the cancer patients to have an AD.
The rate of having an AD among subjects is low in most of
researches. Previous studies indicate that completion of ADs
was 15 to 41 % among the cancer patients [11, 20, 21]; 9 to
70 % among older adults [2, 5, 16, 22]; 15 to 30 % among
general population [23]; 7 % among hemodialysis patients
[24]; 6 % among hematological malignancy patients [25].
Dow reported that 63 % of oncology patients did not know
what an AD was [11], and Ewer doubted about the purpose
and role of ADs [26]. This may explain that a large number of
subjects refused to use ADs.
Recent studies showed that use of ADs was associated with
sociodemographic characteristics [2, 21, 27–30]. Previous
studies have found that persons with ADs documents were
more likely to die at home than in a hospital [2, 18].
Absence of ADs can lead to unwanted aggressive medical
care while patients lacking decision-making capacity [2, 31].
Tan et al. reported that older people and having cancer therapy
weremore likely to have anAD [21]. It was reported that older
age [11, 30] and health insurance [30] were associated with a
greater likelihood of ADs completion. Periyakoil et al. report-
ed that gender, ethnicity, and sub-specialty were the critical
influences on the attitudes toward ADs [27]. Holley et al.
reported that gender, age, race, religion, and education were
significantly associated with ADs completion [28]. However,
in Molloy et al. study, no significant difference was found
between ADs completion and gender [16]. Therefore, there
was no unanimous conclusion between ADs and
sociodemographic characteristics.
Little is known about the association between demographic
characteristics and willing to designate ADs among cancer
patients. Despite the advantage of the ADs, only 10,000
Chinese completed the document of ADs in 2014 [32]. To
the best of our knowledge, no reports were found of Chinese
cancer patients’ completion rate of ADs and the knowledge
and attitudes of approving ADs. The aim of this study was to
investigate knowledge and attitudes of approving ADs and
explore factors associated with willing to designate ADs
among cancer patients in China. It can offer data support to
clinical decision-making and patient education about ADs.
Methods
Study sample
Two departments of oncology from two university hospitals
were involved in this study. Of 753 consecutive cancer pa-
tients admitted to the two hospitals inpatient service between
June 1, 2015 and November 31, 2015, 526 (69 %) were re-
cruited into our study. Of the 227 patients who did not partic-
ipate in the study, 107 were not interested in the research and
they refused our invitation, 57 were not be allowed because of
their illness, 38 failed to complete the questionnaire or inter-
view, 21 were minority who spoke the minority languages and
they did not know Chinese simplified characters, and 4 were
under 18 years. All patients knew their diagnosis of cancer
before participation.
Questionnaire
We used a questionnaire to assess cancer patients’ knowledge
and attitudes toward ADs (Table 1). This questionnaire was
based on previous studies, and most of the questions were
adopted in the questionnaire after modification to fit local
culture and traditions [2, 3, 11, 28, 33–35]. The questionnaire
comprised 25 questions, 11 were designed to gather demo-
graphic clinical characteristics (age, gender, marital status,
education, religion, health insurance, primary tumor site,
etc., and without signature or ID card), 14 were used to collect
information regarding the knowledge and attitudes of cancer
patients. In this questionnaire, patients should answer seven
open-ended questions depending on their knowledge and ex-
perience. Before formal interview, the questionnaire was pilot
Table 1 Main questions in the questionnaire
Do you know about ADs, and how do you know the ADs?
Do you knowwhat anAD is, and what is the purpose ormeaning of ADs?
Who do you prefer to discuss ADs, and why do you choose that? (The
two questions will examine informations about harmonious family
relationship.)
□Spouse □Parent □Child □Oncologist or nurse
Where do you prefer to discuss ADs, and why do you choose that?
□Home □Nursing home □Hospice □Cancer center
When do you prefer to discuss ADs, and why do you choose that?
□Diagnosis immediately □Cancer advanced □Terminally ill
Which kind of care do you need, and why do you choose that?
□Comfort care only □Limited care □All care possible
Where do you want to die, and why do you choose that?
□Home □Nursing home □Hospital
ADs advance directives
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tested with 30 cancer patients in order to revise it for well
understanding and clarity. We also provided the specified
space for the interview.
Data collection
We developed a semi-structured interview for the study to
collect demographic data and assess patient knowledge and
attitudes toward ADs. The information regarding knowledge
and attitudes included (Table 1): (1) whether and how to know
ADs; (2) what is an AD, and what is the purpose or meaning
of ADs; (3) the prefer person, place and time to discuss ADs
topics, and why they choose those; (4) which care the patients
need, and which place they want to die, and why they choose
those. Each of hospital has one clinical nurse to practice the
interview that all participants consented. All the patients were
told information explaining the research and asked not to
share their responses with other patients. The two interviewers
recorded answers to the questions without any attempt to im-
pact on patients’ decisions. Then, data were analyzed by an
independent researcher who was not related to the data collec-
tion. The Ethics Committee of the West China Hospital ap-
proved the study. All the information in our study are confi-
dential and available only by the aim of research.
Data analysis
The patient demographic data and knowledge toward ADs
with statistical description. The chi-squared test was
employed to find significant difference in attitudes of ADs
between the two groups. The binary logistic regression anal-
ysis was used to estimate the odds ratio for each independent
variable, to assess which of the factors associated with willing
to designate ADs. We used SPSS statistic software (version
18.0) to analysis the data. We defined that p value of less than
0.05 will be statistically significant (p value two-sided).
Results
Patients characteristics
The mean age of the cancer patients was 53.6 years (range, 20
to 81 years), 308 (58.6 %) were male, 418 (79.5 %) were
married, 438 (83.3 %) owned health insurance, 134 (25.5 %)
completed college, 398 (75.7 %) lived with family members,
94 (17.9 %) had religion, and 229 (43.5 %) had cancer metas-
tasis. The annual income of the most of subjects (88.2 %) was
under 100K. In terms of ECOG performance status,
208(39.5 %) were 0 scores, 147 (28.0 %) were 1 scores, 123
(23.4 %) were 2 scores, and 48 (9.1 %) were 3 scores
(Table 2).
Knowledge of ADs
All of 526 cancer patients reported that they had not complet-
ed an AD. Ninety-seven percent (510 of 526) of the cancer
patients had not heard of the terminology Badvance directive.^
None of patients can define an AD accurately or know its
purpose before our interviewers told them; however, 46.6 %
(245 of 526) were interested in ADs (data not displayed).
Table 2 Characteristics of 526 study subjects
Variables No. Percentage














Not own 88 16.7
Education
Complete college 134 25.5
Not complete college 392 74.5
Primary tumor site
Head and neck neoplasm 122 23.2
Thoracic neoplasms 134 25.5
Abdominal neoplasms 140 26.6





With family members 398 75.7










SD standard deviation, ECOG Eastern Cooperative Oncology Group
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Attitudes of ADs
Of the 526 cancer patients interviewed, 22.4 % (118 of 526)
approved the ADs, 77.6 % (408 of 526) did not. 55.9 % (66 of
118) of respondents in the approved ADs group preferred to
discuss the ADs topic with oncologist or nurse versus 4.7 %
(19 of 408) of those in the disapproved ADs group
(χ2 = 180.4, p < 0.001). Seventy-five patients in the approved
ADs group were more willing (63.3 versus 3.9 %, p < 0.001)
to discuss about ADs in the place of cancer center than those
in the disapproved ADs group. The respondents who ap-
proved the ADs (77.1 %) were more likely to choose comfort
care near the EOL compared with 56.4 % of those in the
disapproved ADs group (χ2 = 18.8, p < 0.001). In both of
the two groups, a small number of cancer patients (15.9 and
18.6 %, respectively) wanted to discuss the ADs issue at the
time of cancer diagnosis immediately, and most of respon-
dents (72.8 and 73.7 %, respectively) would like to pass away
at home (Table 3).
Influencing factors toward ADs
The binary logistic regression analysis revealed that the older
patients (OR, 1.04, 95 % CI, 1.02–1.07, p = 0.001), female
(OR, 0.55, 95 % CI, 0.35–0.88, p = 0.013), with higher edu-
cation levels (OR, 3.38, 95 % CI, 1.92–5.96, p < 0.001), with
Discussion
From 1985 to 2005, China’s market-oriented medical reform
encouraged hospitals to pursue the profit in order to fill the
breach of public financial subsidy [36, 37]. Consequently, the
medical system did not focus on patients’ autonomy. The pa-
tients also lacked of consciousness of maintaining their rights
and interests. So we did not develop an AD at that time. But
from 2006, the disease-centered health service is gradually
transformed into patient-centered health service in our country
[36]. And then, we started to debate ADs. Though ADwas far
from common in China, it has legalized in many countries [20,
38, 39]. Because of the medical system, 77.6 % (408 of 526)
of patients in this study disapproved ADs. Our study also
showed that none of respondents knew what was an AD or
completed it, and most of them had not heard of the term
Badvance directive.^ However, 46.6 % (245 of 526) were
Table 3 Comparing with







With whom to discuss the topic 180.4 <0.001
Spouse 174 (42.6) 24 (20.4)
Parent 116 (28.4) 9 (7.6)
Child 99 (24.3) 19 (16.1)
Oncologist or nurse 19 (4.7) 66 (55.9)
When to discuss the topic 4.12 0.127
Diagnosis immediately 65 (15.9) 22 (18.6)
Cancer advanced 180 (44.1) 61 (51.7)
Terminally ill 163 (40.0) 35 (29.7)
Where to discuss the topic 244.1 <0.001
Home 228 (55.9) 12 (10.2)
Nursing home 112 (27.5) 11 (9.3)
Hospice 52 (12.7) 20 (16.9)
Cancer center 16 (3.9) 75 (63.6)
What care to need 18.8 <0.001
Comfort care only 230 (56.4) 91 (77.1)
Limited care 137 (33.6) 25 (21.2)
All care possible 41 (10.0) 2 (1.7)
Where to die 2.35 0.309
Home 297 (72.8) 87 (73.7)
Nursing home 58 (14.2) 21 (17.8)
Hospital 53 (13.0) 10 (8.5)
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religious beliefs (OR, 2.91, 95 % CI, 1.71–4.94, p < 0.001), and
with higher scores of ECOG (OR, 1.46, 95 % CI,
1.17–1.82, p = 0.001) were more likely to have willingness to
designate ADs. The factors that not emerged in binary logistic
regression analysis as associated with the willing to designate
ADs were marital status, income, health insurance, primary
tumor site, metastases, and living situation (Table 4).
interested in ADs and 22.4 % (118 of 526) approved the ADs.
Nowadays, more and more attention has been paid to the ADs
in China. From 2010 to 2016, some of the National People’s
Congress (NPC) delegates formally submitted proposal about
setting up regulation of ADs to the NPC. At 2013, the Beijing
LivingWill Promotion Association (BLWPA) was established
as a non-governmental organization. By BLWPA’s steady ef-
fort, millions of Chinese are familiar with ADs, and 10,000
Chinese complete the document of ADs in 2014 [30].
As found in previous studies, life-sustaining treatment not
only exhausted patients and caregivers’ body and spirits but
also wasted of the country’s precious health resources [15, 25,
40–42]. In their view, the expenditures of aggressive therapy
near EOL were pointless. Our finding also showed that most
of the cancer patients choose comfort care or limited care
instead of resuscitation, ventilation, intubation, and they
thought aggressive therapy had no dignity. In addition, some
studies have demonstrated that ADs were associated with less
life-sustaining treatment [2, 5]. Nicholas et al. study indicated
that ADs were related to significantly lower levels of medical
expenditures, higher utilization of health care resources, and
higher rates of at-home deaths indirectly [15]. It is necessary
to design ADs education program to spread information of
ADs and death with dignity for further discussing with them.
The role of trust as a core element of shared decision-
making is important for ADs [43]. It was very interesting that
nearly half of (54 of 118) cancer patients who endorsed ADs
had no harmonious family relationship, in contrast, most of
(369 of 408) cancer patients who did not endorse ADs had
harmonious family relationship. It was similar that the ap-
proved ADs group patients who had no harmonious family
relationship were more likely to communicate with doctors or
nurses in hospital, on the contrary, the approved ADs group
patients who had harmonious family relationship were more
likely to discuss ADs topic with their family members at
home. The cancer patients trusted the family members more,
if they had harmonious family relationship; the patients
trusted the doctors or nurses more, if they had no harmonious
family relationship. Patients prefer the person whom they
trusted to participate in their medical decision-making [44,
45]. For medical staff, good communication should be made
to foster patients’ trust and improve the medical decision-
making process.
The physicians are uncertain about when is the best time to
talk about dying with the patients [46]. Our results indicate
that most of participants chose cancer progression was the best
time to discuss, and home was the best place to die. At the
beginning of cancer disease, patients subconsciously feel that
talking about end of life might somehow bring it about [46],
so, they do not like involving ADs and they would like ac-
tively participating in medical decision. Instead, advanced
cancer patients often gave up the medical decision-making
about treatment regimens [47], they begin to discuss death
because they have awareness that such a terminal stage is
coming, this may be a good time to discuss ADs. In addition,
Chinese patients prefer to die in peace at home as long as the
condition is permitted, and they think facing death is like a
fallen leaf at the EOL. The willing to die at home is deter-
mined by the traditional cultural background of China.
Therefore, Chinese death philosophy is ingrainedly influenced
by Confucianism which is the core idea of our traditional
culture [48, 49].
In this study, cancer patients who approved an AD tended
to be older than those who did not. This was consistent with
previous studies [11, 21, 33, 35]. Usually, the older cancer
patients talk about the death much more than the younger
patients, and most of them desire for death with dignity, but
they are not sure how to die, therefore, they willing to use ADs
to put their wishes on paper. By this way, it could not bring
mental burden to their family members and friends.
Our founding indicated that fewer males approved ADs
than females. The result was the same as Blackmer et al.
[29]; however, this was in contrast to the finding of
Trarieux-Signol et al. study [25]. The reasons for this contra-
diction are not known, although it could be caused by different
personality, different population, and different sample size.
Needing much more data to clarify whether males discuss or
register ADs more than females.
Cancer patients with higher education levels have signifi-
cantly higher rates of approved ADs. This parallels the find-
ings of Mahaney-Price et al. and Freer et al. [30, 33]. In our
interview, participants with higher education levels accepted
the usefulness of ADs, in addition, if the low-education par-
ticipants internally comprehended of ADs they would also
honor ADs. So the key point is to perform educational pro-
gramming of ADs for cancer patients.
It appears from our study that religious patients were more
likely to endorse ADs. This is similar to previous studies
Table 4 Analysis by binary logistic regression of the factors associated
with willing to designate ADs
Variables Odds ratio 95 % CI p value
Age 1.04 [1.02–1.07] 0.001
Gender 0.55 [0.35–0.88] 0.013
Marital status 1.67 [0.90–3.08] 0.098
Income 1.09 [0.83–1.43] 0.514
Health insurance 1.23 [0.63–2.39] 0.543
Education 3.38 [1.92–5.96] <0.001
Primary tumor site 1.11 [0.90–1.36] 0.308
Metastases 0.91 [0.57–1.45] 0.705
Living situation 1.17 [0.79–1.72] 0.429
Religiousness 2.91 [1.71–4.94] <0.001
ECOG performance status 1.46 [1.17–1.82] 0.001
ECOG Eastern Cooperative Oncology Group
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which demonstrated that religion was significantly associated
with having an AD [25, 50]. Generally, the patients approve
religion as an important consideration in their life [51]. The
religious participants told us that manner of death and self-
medical-decision should be in accord with their religious doc-
trine and values. They often discussed state of illness and
treatment plan while hospitalized, and they preferred to
choose comfort care or limited care near the EOL because of
the faith. However, in this study, the participants thought that
health care providers rarely paid attention to their religious
ideas.
Studies suggested quality of life played an important role in
the ADs completion [52, 53]. Patients pay great concern to
quality of life during making medical decision. Our logistic
regression analysis suggested that higher scores of ECOG
correlate with an increased rate of favored ADs. This implies
that cancer patients with poorer quality of life were more like-
ly to choose ADs. The result might reflect that those patients
had a high opinion of ADs, mainly thanks to the improved
quality of life they wanted.
In order to improve the cancer patients’ knowledge and
attitude toward ADs, health education about advance care
planning should be adopted to create a trust relationship be-
tween patients and healthcare providers, and make them ac-
cept the concept that cancer is a chronic disease, then the
physicians will initiate discussions of preferences and goals
about patients’ health care; and through the flat media and the
net, we should propagandize excellently so as to draw more
attention from people all over the country to concern about the
ADs, if more people debate the ADs, our government may set
policy to adapt the development of society.
The present study had some limitations. First, our sample
size was small, larger samples were needed to validate the
conclusion. Second, we did not interview the 107 cancer pa-
tients who were not interested in the research. There may be
some value information about why did they refuse to partici-
pate in our research. Third, the study from only two cancer
centers may have selection bias. Multicenter studies are need-
ed to validate the ADs preference and factors associated with
willing to designate ADs among cancer patients.
In conclusion, cancer patients lack of knowledge of ADs,
and none of them had an AD in China. Though only 22.4 %
(118 of 526) approved ADs, 46.6 % (245 of 526) were inter-
ested in ADs. In this study, most of cancer patients wished to
have comfort or limited care, and to die at home. The medical
system, tradition culture of Confucian, and lack of knowledge
made the non-approval of ADs so high in our sample. In
addition, the approved ADs patients were more likely to dis-
cuss the ADs with health providers in the cancer center at the
progression of cancer. In binary logistic regression analysis,
the older patients, female, with higher education levels, with
religions, and with higher scores of ECOG showed associa-
tion with the willing to designate ADs.
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